ES2052761T3 - Nuevos esteres del acido androstano 17-carboxilico, procedimiento para su preparacion y medicamento que los contiene. - Google Patents

Nuevos esteres del acido androstano 17-carboxilico, procedimiento para su preparacion y medicamento que los contiene.

Info

Publication number
ES2052761T3
ES2052761T3 ES88402476T ES88402476T ES2052761T3 ES 2052761 T3 ES2052761 T3 ES 2052761T3 ES 88402476 T ES88402476 T ES 88402476T ES 88402476 T ES88402476 T ES 88402476T ES 2052761 T3 ES2052761 T3 ES 2052761T3
Authority
ES
Spain
Prior art keywords
androstan
carboxylic
procedure
preparation
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88402476T
Other languages
English (en)
Inventor
Francois-Xavier Jarreau
Jean-Jacques Koenig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NATIVELLE LAB
Original Assignee
NATIVELLE LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NATIVELLE LAB filed Critical NATIVELLE LAB
Application granted granted Critical
Publication of ES2052761T3 publication Critical patent/ES2052761T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A ACIDOS DE ANDROSTANO 17 CARBOXILICO, REPRESENTADOS POR LA FORMULA(I) QUE SE DESCRIBE EN LA INVENCION. APLICACION EN TERAPEUTICA, PARTICULARMENTE PARA EL TRATAMIENTO DE LA INSUFUCIENCIA CARDIACA.
ES88402476T 1987-10-02 1988-09-30 Nuevos esteres del acido androstano 17-carboxilico, procedimiento para su preparacion y medicamento que los contiene. Expired - Lifetime ES2052761T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8713658A FR2621316B1 (fr) 1987-10-02 1987-10-02 Nouveaux esters d'acide androstane 17-carboxylique, procede pour leur preparation, et medicament les contenant

Publications (1)

Publication Number Publication Date
ES2052761T3 true ES2052761T3 (es) 1994-07-16

Family

ID=9355472

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88402476T Expired - Lifetime ES2052761T3 (es) 1987-10-02 1988-09-30 Nuevos esteres del acido androstano 17-carboxilico, procedimiento para su preparacion y medicamento que los contiene.

Country Status (22)

Country Link
US (1) US4885280A (es)
EP (1) EP0310519B1 (es)
JP (1) JP2783560B2 (es)
KR (1) KR970002642B1 (es)
AT (1) ATE79630T1 (es)
AU (1) AU607100B2 (es)
CA (1) CA1306248C (es)
DE (1) DE3873870T2 (es)
DK (1) DK165595C (es)
EG (1) EG19114A (es)
ES (1) ES2052761T3 (es)
FI (1) FI89055C (es)
FR (1) FR2621316B1 (es)
GR (1) GR3005968T3 (es)
HK (1) HK60297A (es)
IE (1) IE61941B1 (es)
IL (1) IL87894A (es)
MY (1) MY103635A (es)
NO (1) NO173011C (es)
NZ (1) NZ226433A (es)
PT (1) PT88648B (es)
ZA (1) ZA887396B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5209926A (en) * 1990-06-12 1993-05-11 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5252319A (en) * 1990-06-12 1993-10-12 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5256408A (en) * 1990-06-12 1993-10-26 Insite Vision Incorporated Aminosteroids for ophthalmic use
WO1993005790A1 (en) * 1991-09-27 1993-04-01 Procter & Gamble Pharmaceuticals, Inc. Use of 14-aminosteroids for the manufacture of a medicament to slow the rate of progression of myocardial structural damages characteristic of congestive heart failure
EP0647234A1 (en) * 1992-06-26 1995-04-12 Pfizer Inc. Steroidal glycosides for treating hypercholesterolemia
EP0720616A1 (en) * 1993-09-24 1996-07-10 The Procter & Gamble Company Novel deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds
AU700131B2 (en) * 1993-09-24 1998-12-24 Procter & Gamble Company, The Novel deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds
US5922703A (en) * 1993-09-24 1999-07-13 The Procter & Gamble Company Urethane-containing aminosteroid compounds
HUT74623A (en) * 1993-09-24 1997-01-28 Procter & Gamble Novel oligosaccharide-containing 14-aminosteroid compounds, pharmaceutical compositions containing the same and novel diastereoselective aminosteroid process for producing them
CA2258202A1 (en) * 1996-06-17 1997-12-24 The Procter & Gamble Company Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds for use as an antiarrhythmic
ES2347027T3 (es) 1998-05-22 2010-10-22 The Board Of Trustees Of The Leland Stanford Junior University Moleculas bifuncionales y terapias basadas en las mismas.
EP2671507A3 (en) 2005-04-28 2014-02-19 Proteus Digital Health, Inc. Pharma-informatics system
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
CA2752373C (en) 2009-02-20 2017-10-10 To-Bbb Holding B.V. Glutathione-based drug delivery system
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
GB201112402D0 (en) 2011-07-19 2011-08-31 British American Tobacco Co Cellulose acetate compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449381A (en) * 1962-06-12 1969-06-10 Syntex Corp 19-oxo- and 19-lower alkyl-19-oxoandrostane derivatives
US3634409A (en) * 1966-04-26 1972-01-11 Syntex Corp 3beta-tetrahydrofuran-2'-yloxy-delta**4-steroids of the androstane and estrane series
FR2464270A1 (fr) * 1979-08-31 1981-03-06 Nativelle Sa Ets Nouveaux derives d'amino-14 steroides, et procede pour leur preparation
ES524796A0 (es) * 1982-08-20 1984-05-01 Nativelle Sa Ets Procedimiento de preparacion de nuevos derivos de amino-14 esteroides
NZ205293A (en) * 1982-08-20 1986-12-05 Nativelle Sa Ets 14-aminosteroids and pharmaceutical compositions

Also Published As

Publication number Publication date
EP0310519B1 (fr) 1992-08-19
EG19114A (fr) 1994-07-30
FI884511A7 (fi) 1989-04-03
NO173011B (no) 1993-07-05
DE3873870D1 (de) 1992-09-24
AU607100B2 (en) 1991-02-21
IL87894A (en) 1994-02-27
FI884511A0 (fi) 1988-09-30
DK165595C (da) 1993-05-03
FI89055C (fi) 1993-08-10
FR2621316A1 (fr) 1989-04-07
JPH01156995A (ja) 1989-06-20
KR890006667A (ko) 1989-06-15
DK165595B (da) 1992-12-21
PT88648A (pt) 1988-10-01
DE3873870T2 (de) 1993-02-18
EP0310519A1 (fr) 1989-04-05
AU2293588A (en) 1989-04-06
IE61941B1 (en) 1994-11-30
DK549388A (da) 1989-04-03
DK549388D0 (da) 1988-09-30
NO173011C (no) 1993-10-13
US4885280A (en) 1989-12-05
MY103635A (en) 1993-08-28
FI89055B (fi) 1993-04-30
JP2783560B2 (ja) 1998-08-06
PT88648B (pt) 1992-12-31
IL87894A0 (en) 1989-03-31
NZ226433A (en) 1991-06-25
GR3005968T3 (es) 1993-06-07
IE882991L (en) 1989-04-02
HK60297A (en) 1997-05-16
ATE79630T1 (de) 1992-09-15
NO884344D0 (no) 1988-09-30
NO884344L (no) 1989-04-03
KR970002642B1 (ko) 1997-03-07
ZA887396B (en) 1991-11-27
CA1306248C (en) 1992-08-11
FR2621316B1 (fr) 1991-06-21

Similar Documents

Publication Publication Date Title
ES2052761T3 (es) Nuevos esteres del acido androstano 17-carboxilico, procedimiento para su preparacion y medicamento que los contiene.
ES2054860T3 (es) Nuevos derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion, asi como a su utilizacion como medicamentos.
ES2122076T3 (es) Derivados de nor-acidos biliares, procedimiento para su preparacion y utilizacion de estos compuestos como medicamentos.
ES2136677T3 (es) Derivados monomeros de acidos biliares, procedimiento para su preparacion y utilizacion de estos compuestos como medicamentos.
ES2108144T3 (es) Benzoilguanidinas sustituidas en orto, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
ES2178779T3 (es) Nuevas amidas de acidos de piridil alcanos como agentes citoestaticos e inmunosupresores.
ES2042582T3 (es) Un procedimiento para preparar una composicion de sustancia que tiene una actividad fisiologica y nutricional util.
ES2073533T3 (es) Uso antivirico de composiciones que constan de acidos grasos esenciales e interferon.
ES8705842A1 (es) Procedimiento para la preparacion biotecnologica de acidos alfa-arilalcanoicos activos opticamente
ES2130472T3 (es) Guanididas de acidos alquenilcarboxilicos sustituidas con fenilo, portadoras de grupos perfluoroalquilo, procedimiento para su preparacion, su uso como medicamento o agente diagnostico, asi como medicamento que las contiene.
ES2038359T3 (es) Procedimiento para la obtencion de formulaciones inyectables intramusculares de inhibidores de girasa.
ES460098A1 (es) Metodo para producir derivados de acido penicilanico.
ES2045009T3 (es) El acido taurohyodesoxicolico para la terapia de calculosis del tracto biliar y de la dispepsia biliar.
ES8306754A1 (es) "procedimiento para la preparacion de nuevos derivados de azepina".
ES8704957A1 (es) Procedimiento para preparar alfa-aminoacidos sustituidos
ES8303404A1 (es) Procedimiento para preparar 3-amino-sidnoniminas sustituidas.
ES8203376A1 (es) Procedimiento para obtener acidos 6-cloro- o 6-bromo-1,2-di-hidro-3h-pirrolo(1,2-a)pirrol-1-carboxilicos y sus derivados
ES8503676A1 (es) Procedimiento de producir derivados de acido oxazolacetico
ES8100263A1 (es) Procedimiento para preparar un derivado de acido 1-bencil-1,2,5,6-tetrahidropiridina-3-carboxilico
ES2108977T3 (es) Derivados del acido hidroximetilfurazanocarboxilico y su utilizacion en el tratamiento de enfermedades cardiovasculares.
ES461785A1 (es) Un metodo para la preparacion de un ester de acido behenico.
ES8701725A1 (es) Procedimiento para la preparacion de 1,4-dihidropiridina-hidroximina.
ES8502435A1 (es) Un metodo para preparar 2(1h)-piridinonas
ES8801811A1 (es) Procedimiento para preparar acidos hexenoicos
ES8308551A1 (es) Procedimiento para la preparacion de derivados de tiazolina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 310519

Country of ref document: ES